Comparison of uptake of colorectal cancer screening based on fecal immunochemical testing (FIT) in males and females: A systematic review and meta-analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 1, 2015, Pages 39-47

  Clarke, Nicholas ^a,b   Sharp, Linda ^a   Osborne, Aoife ^c   Kearney, Patricia M ^b  

^a National Ancer Registry Ireland Building 6800 ^*  (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c South East Technological University   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONFIDENCE INTERVAL; EMBASE; FECAL IMMUNOCHEMICAL TESTING; FECES ANALYSIS; HEALTH CARE UTILIZATION; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; SCREENING TEST; SEX DIFFERENCE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FECES; FEMALE; IMMUNOHISTOCHEMISTRY; MALE;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE;

EID: 84921063699     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0774     Document Type: Article

References (46)

1. International Agency for Research on Cancer.GLOBOCAN2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. [cited 2014 Oct 17]. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
2. Konishi F, Morson BC. Pathology of colorectal adenomas: a colonoscopic survey. J Clin Pathol 1982;35:830-41.
3. European Colorectal Cancer Screening Guidelines Working Group, von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy 2013; 45:51-9.
4. Colorectal Cancer Screening (PDQ®) [Internet]. National Cancer Institute. [cited 2014 Oct 17]. Available from: http://www.cancer.gov/cancertopics/pdq/screening/colorectal/HealthProfessional/page1.
5. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467.
6. Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JMA, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375: 1624-33.
7. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541-9.
8. Burch JA, Soares-Weiser K, St John DJB, Duffy S, Smith S, Kleijnen J, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen 2007;14: 132-7.
9. Alexander F, Weller D. Evaluation of the UK Colorectal cancer screening pilot. Edinb Www Cancerscreening Nhs Ukcolorectalpilot Html Ed [Internet]. 2003 [cited 2014 Oct 17]. Available from: http://www.screening.org.uk/bowel/finalreport.pdf.
10. Colorectal cancer screening activities in ICSN countries [Internet]. [cited 2014 Oct 17]. Available from: http://appliedresearch.cancer.gov/icsn/colorectal/screening.html.
11. Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS, et al. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer 2008;122:1357-67.
12. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009;15: 5907-15.
13. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
14. Khalid-de Bakker C, Jonkers D, Smits K, Mesters I, Masclee A, Stockbrügger R. Participation in colorectal cancer screening trials after first-time invitation: a systematic review. Endoscopy 2011;43:1059-86.
15. Vart G, Banzi R, Minozzi S. Comparing participation rates between immunochemical and guaiac faecal occult blood tests: a systematic review and meta-analysis. Prev Med 2012;55:87-92.
16. Evans REC, Brotherstone H, Miles A, Wardle J. Gender differences in early detection of cancer. J Mens Health Gend 2005;2:209-17.
17. Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev 2006;15:389-94.
18. Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, et al. How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med 2010;50:165-72.
19. Cochrane handbook for systematic reviews of interventions [Internet]. [cited 2014 Oct 17]. Available from: http://handbook.cochrane.org/.
20. Ottawa Hospital Research Institute [Internet]. [cited 2014 Oct 17]. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp.
21. Welch HG, Black WC. Evaluating randomized trials of screening. J Gen Intern Med 1997;12:118-24.
22. Park MJ, Choi KS, Jun JK, LeeH-Y. Trends in theNational Cancer Screening Program for colorectal cancer in the Republic of Korea, 2004-2009. Asian Pac J Cancer Prev 2011;12:3489-93.
23. Cole SR, Young GP, Byrne D, Guy JR, Morcom J. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002;9: 147-52.
24. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10: 117-22.
25. Crotta S, Castiglione G, GrazziniG, Valle F, Mosconi S, Rosset R. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol 2004;16:33-7.
26. Fenocchi E, Martínez L, Tolve J, Montano D, Rondan M, Parra-Blanco A, et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer 2006;15:384-90.
27. Chen L-S, Liao C-S, Chang S-H, Lai H-C, Chen TH-H. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J Med Screen 2007;14:191-9.
28. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
29. Parente F, Marino B, DeVecchi N, Moretti RLecco Colorectal Cancer Screening Groupm, Ucci G, et al. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg 2009;96:533-40.
30. Levy BT, Daly JM, Luxon B, Merchant ML, Xu Y, Levitz CE, et al. The "iowa get screened" colon cancer screening program. J Prim Care Community Health 2010;1:43-9.
31. Cai S-R, Zhang S-Z, Zhu H-H, Huang Y-Q, Li Q-R, Ma X-Y, et al. Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res Phila 2011;4:1572-9.
32. Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G. Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer. BMC Public Health 2011;11:38.
33. Senore C, Ederle A, Benazzato L, Arrigoni A, Silvani M, Fantin A, et al. Offering people a choice for colorectal cancer screening. Gut 2013;62: 735-40.
34. Hol L, Kuipers EJ, van Ballegooijen M, van Vuuren AJ, Reijerink JCIY, Habbema DJF, et al. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme. Int J Cancer 2012;130:2096-102.
35. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
36. Ferrari Bravo M, De Conca V, Devoto GL, Sironi M, Mele R, Fumagalli A, et al. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round. J Prev Med Hyg 2012;53:37-43.
37. McDonald PJ, Strachan JA, Digby J, Steele RJC, Fraser CG. Faecal haemoglobin concentrations by gender and age: implications for populationbased screening for colorectal cancer. Clin Chem Lab Med 2012;50: 935-40.
38. Kluhsman BC, Lengerich EJ, Fleisher L, Paskett ED, Miller-Halegoua SM, Balshem A, et al. A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009. Prev Chronic Dis 2012;9:E77.
39. Gupta S, Halm EA, Rockey DC, Hammons M, Koch M, Carter E, et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med 2013;173:1725-32.
40. Kelley L, Swan N, HughesDJ. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme. Colorectal Dis 2013;15:e512-21.
41. Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN, et al. Colorectal cancer screening barriers and facilitators in older persons. Prev Med 2010;50:3-10.
42. Payne S. Not an equal opportunity disease-a sex and gender-based review of colorectal cancer in men and women: Part II. J Mens Health Gend 2007;4:251-6.
43. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997;89:1406-22.
44. Chapple A, Ziebland S, Hewitson P, McPherson A. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study. Soc Sci Med 2008;66:2425-35.
45. Ritvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L. Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health 2013;13:500.
46. White A, de Sousa B, de Visser R, Hogston R, Madsen S, Makara P, et al. The state of health in the European Community-European Commission [Internet]. [cited 2014 Oct 17]. Available from: http://ec.europa.eu/health/reports/european/programme/state-health/index-en.htm.